PNT2258: Phase II started

ProNAi began the open-label, international Phase II Brighton trial to evaluate 120 mg/m 2 IV PNT2258 on days 1-5 of each 21-day cycle for 8 induction cycles followed by a 100 mg/m 2 dose on days 1-4 o...